• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,319.55 185.23
( 0.25%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,162.49 699.22
(1.33%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.02 -0.15
(-0.16%)
EUR-INR
107.32 -0.65
(-0.60%)
GBP-INR
123.03 -0.78
(-0.63%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

Astec Lifesciences Ltd
Industry :  Pesticides / Agrochemicals - Indian
BSE Code
ISIN Demat
Book Value()
533138
INE563J01010
185.4470534
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASTEC
0
1206.25
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

NTPC rises after Q3 PAT jumps 8% YoY to Rs 5,597 cr
Feb 01,2026
The revenue from power generation activity stood at Rs 44,657.81 in Q3 FY26, up 1.29% YoY. During the period under review, the company recorded Rs 4,894.80 crore as other income, up 17.82% YoY.

Profit before tax and regulatory deferral account balances declined 2.67% YoY to Rs 7,385.27 crore in Q3 FY26 from Rs 7,587.90 crore in Q3 FY25.

Total expense rose 2.77% year on year to Rs 39,533.23 crore during the quarter. Employee benefits expense was at Rs 1,756.72 crore (up 8.23% YoY), while other expenses stood at Rs 5,297.09 crore (up 34.48% YoY) during the period under review.

Meanwhile, the company’s board approved a second interim dividend for FY26 at 27.5%, or Rs 2.75 per share on a face value of Rs 10. The dividend is scheduled for payment and dispatch on 25 February 2026.

NTPC, along with its subsidiaries/associates & JVs, is primarily involved in the generation and sale of bulk power to state power utilities. Other business of the group includes providing consultancy, project management & supervision, energy trading, oil & gas exploration, and coal mining.